Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other 1

Conditions

Obesity 1Metabolic Syndrome 1Inflammation 1Dyslipidemias 1

Interventions

Surgical Procedures, Operative 2Blood Specimen Collection 2ziprasidone 1semaglutide 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1Zolpidem 1Weights and Measures 1Warfarin 1Vecuronium Bromide 1Vancomycin 1Tranexamic Acid 1Topiramate 1Tobramycin 1Tirzepatide 1Spironolactone 1Sevelamer 1Rocuronium 1Radiotherapy 1Qsymia 1Piperacillin, Tazobactam Drug Combination 1Pioglitazone 1Phentermine 1Pentobarbital 1Oxycodone 1Nifedipine 1Neoadjuvant Therapy 1Naltrexone 1Nafcillin 1Molindone 1Methylprednisolone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Inflammation × Topiramate × Clear all
NCT05756764 2025-09-09

Anti-obesity Pharmacotherapy and Inflammation

Louisiana State University Health Sciences Center in New Orleans

Active not recruiting
30 enrolled
Other

Inflammation, Obesity, Metabolic Syndrome, Dyslipidemias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡